Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L7a pseudogene 61 (RPL7AP61) is a non-coding DNA sequence in the human genome that resembles the functional ribosomal protein L7a (RPL7A) gene but does not encode a protein product. Pseudogenes such as RPL7AP61 are considered to be genomic "fossils" formed through gene duplication or retrotransposition events that subsequently acquired mutations preventing expression of a functional protein. RPL7AP61 is not believed to have a direct biochemical or therapeutic role; its potential functions are limited to possible gene regulation or genomic structural roles specific to certain contexts, but no such functions have been established for this pseudogene. The functional, protein-coding gene in this family is RPL7A, which encodes a ribosomal protein essential for protein synthesis. RPL7AP61 itself is one of many processed pseudogenes dispersed throughout the human genome.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7a pseudogene 61 (RPL7AP61).